Supplement guide

Carrot - Daucus Carota subsp. Sativus

Learn about the uses, forms, amounts, and precautions for Carrot - Daucus Carota subsp. Sativus. This guide brings the relevant conditions together so you can see who the information covers, how preparations differ, and what to consider before use.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team · Sources and editorial method

First released · Updated · View changes

What is it used for?

General

  • Provitamin A/Source of vitamin A for the maintenance of good health [Source note 2].

  • Source of vitamin A.

Specific

  • Helps to prevent vitamin A deficiency¹ [Source note 3].

  • (Provitamin A/Source of vitamin A to) help(s) in the development and maintenance of bones [Source note 4].

  • (Provitamin A/Source of vitamin A to) help(s) in the development and maintenance of night vision [Source note 5].

  • (Provitamin A/Source of vitamin A to) help(s) in the development and maintenance of teeth [Source note 6].

  • (Provitamin A/Source of vitamin A to) help(s) maintain eyesight, skin, membranes and immune function [Source note 7].

  • The above uses can be combined on the product label (e.g., Source of vitamin A to help maintain eyesight, skin, membranes and immune function and to help in the development and maintenance of night vision, bones and teeth).

  • ¹Vitamin A deficiency claim: Refer to Table 3 for the dose requirements.

Who does this guide cover?

As specified below.

How is it taken?

Oral

Which forms are covered?

this reference excludes foods or food-like dosage forms as indicated in the Compendium of references Guidance Document.

Acceptable dosage forms by age group:

Children 1-2 years: The acceptable dosage forms are limited to emulsion/suspension and solution/liquid preparations (Giacoia et al. 2008; EMA/CHMP 2006).

Children 3-5 years: The acceptable dosage forms are limited to chewables, emulsion/suspension, powders and solution/liquid preparations (Giacoia et al. 2008; EMA/CHMP 2006).

Children 6-11 years, Adolescents 12-17 years, and Adults 18 years and older: The

Quantities

Methods of preparation: Powdered standardized; Standardized extracts

In addition to the quantity of carrot powder/extract, the potency information must be expressed as the quantity of beta-carotene.

All uses except vitamin A deficiency

Table 2. Dose information of beta-carotene (micrograms) per day
Subpopulation(s)Subpopulation(s)beta-carotene (µg/day)¹,² / Minimumbeta-carotene (µg/day)¹,² / Maximum
Children1-3 years180 µg3,600 µg
Children4-8 years180 µg5,400 µg
Adolescents9-13 years180 µg10,200 µg
Adolescents14-18 years390 µg16,800 µg
Adults19 years and older390 µg18,000 µg

¹Values were derived from the conversion factor of 6 μg of beta-carotene = 1 μg all-trans retinol; hence, a ratio of 6:1 beta-carotene: vitamin A, on a weight to weight basis (HC 1990; FAO/WHO 1967). ²Minimum doses based on approximately 5% of the highest AI or RDA for vitamin A, and the maximum doses based on the UL for vitamin A [Source note 8].

Vitamin A deficiency claim

Table 3. Dose information of beta-carotene (micrograms) per day for Vitamin A deficiency claim
Subpopulation(s)Subpopulation(s)beta-carotene (µg/day)¹ / Minimumbeta-carotene (µg/day)¹ / Maximum
Children1-3 years1,800 µg3,600 µg
Children4-8 years2,400 µg5,400 µg
Adolescent males9-13 years3,600 µg10,200 µg
Adolescent males14-18 years5,400 µg16,800 µg
Adult males19 years and older5,400 µg18,000 µg
Adolescent females9-13 years3,600 µg10,200 µg
Adolescent females14-18 years4,200 µg16,800 µg
Adult females19 years and older4,200 µg18,000 µg
Pregnancy14-18 years4,500 µg16,800 µg
Pregnancy19-50 years4,620 µg18,000 µg
Breastfeeding14-18 years7,200 µg16,800 µg
Breastfeeding19-50 years7,800 µg18,000 µg

¹These values are based on the RDA and AI values for vitamin A based on subpopulations [Source note 9] and were derived from the conversion factor of 6 µg of beta-carotene = 1 µg all-trans retinol; hence, a ratio of 6:1 beta-carotene:vitamin A, on a weight to weight basis (HC 1990; FAO/WHO 1967).

How is it used?

The reference does not require an additional label statement in this section. This does not establish an absence of risk.

How long is it used?

The reference does not require an additional label statement in this section. This does not establish an absence of risk.

Warnings and precautions

Products providing more than 6,000 μg of beta-carotene, per day

Ask a healthcare professional before use if you are a tobacco smoker [Source note 10].

When should it be avoided?

The reference does not require an additional label statement in this section. This does not establish an absence of risk.

Possible side effects

The reference does not require an additional label statement in this section. This does not establish an absence of risk.

Storage

Must be established in accordance with the requirements described in the applicable product regulations.

Preparation details

Ingredient identity, preparation requirements, and other details that define the scope of this guide.

Ingredients and preparations
Table 1. Proper name(s), Common name(s), Source information
Proper name(s)Common name(s)Source information / Source material(s)Source information / Part(s)Source information / Preparation(s)
Daucus carota subsp. sativusCarrotDaucus carota subsp. sativusRootDry

References: Proper name: USDA 2024; Gardner and McGuffin 2013; Common name: USDA 2024; Gardner and McGuffin 2013; Source information: CNF 2024; USDA 2024.

Other ingredients

Must be chosen from the current source ingredient database and must meet the limitations outlined in the database.

Preparation and quality requirements
  • The finished product specifications must be established in accordance with the requirements described in the source authority source’s product quality guidance.

  • The active ingredient must comply with the requirements outlined in the source ingredient database.

Guide change history

Updates to this SupplementSafety.org guide.

  1. Minor updates

    Updated guide wording, organization, and source presentation. Added our editorial change history.

  2. Initial release

    Initial SupplementSafety.org guide prepared from source reference material.

Validation: Not yet completed. Editorial updates do not constitute clinical validation.

Sources

Source information

This guide organizes source material about uses, preparations, amounts, and precautions. Read the conditions alongside each statement; the information may apply only to particular preparations or populations.

The source document includes supporting references. We have not independently summarized or assessed every cited study for this guide.

Source document version
January 30, 2026
Source captured
Aug 15, 2026
Editorial work
Editorial preparation. Independent clinical review has not been recorded for this guide.

Full citations are available through the link above. Verification is required to open them; reading this guide does not require verification.

Taking a medication too?

Explore our supplement–medication interaction checker. Its coverage and review status are shown with the results; a missing finding does not establish that a combination is safe.

Browse all supplement guides →